The Core Momentum Strategy is an equity portfolio that concentrates on stocks with both price momentum and improving fundamentals. We conduct bottom-up research to identify companies with sustained economic moats and resilient business models, as well as emerging leaders with disruptive technologies and accelerating growth. We also invest in turnaround candidates with a clear path to regain dominance in their respective markets after a major setback.
The Strategy seeks to achieve long-term capital appreciation by investing in a diversified portfolio of liquid U.S. equities exhibiting strong and persistent price momentum. The Strategy primarily targets large-capitalization and select mid-capitalization equities, typically emphasizing a growth-oriented investment style while retaining the flexibility to adapt across style factors as momentum shifts.
Our portfolio strategy emphasizes diversification, disciplined risk management, and liquidity. We invest in stocks with sufficient liquidity to ensure ease of trading and efficient execution. The portfolio typically consists of 30 to 50 holdings, with a normal position size ranging from 3% to 5% of total assets. To prevent excessive exposure, we limit individual security concentration to no more than 10%.
Sector exposure is also managed prudently, typically capped at 35% or 1.5 times the benchmark weight, whichever is greater. The portfolio is typically fully invested, reflecting our conviction in selected holdings and our goal of maintaining market exposure.
To monitor and control portfolio risk, we regularly review quantitative risk management statistics. This allows us to identify where risk is concentrated and in what form it exists, enabling proactive adjustments and maintaining alignment with our risk and return objectives.
As of
September 30, 2026




As of
September 30, 2026
Please see the Glossary for descriptions of these terms.
As of
September 30, 2026
As of
September 30, 2026
As of
September 30, 2026
Risk/Return Metrics based on rolling 5-year period measured quarterly. Past performance is no guarantee of future results. Investing involves risks, including the possible loss of
principal.
Please see the Glossary for descriptions of these terms.
As of
September 30, 2026
As of
September 30, 2026
Past performance is no guarantee of future results. Investing involves risks, including the possible loss of the principal amount invested. The use of Alpine Saxon Woods does not eliminate risks associated with investing. Consider the investment objectives, risks, charges, and expenses carefully before investing. The information presented has been obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. Opinions, estimates and projections constitute the judgment of Alpine Saxon Woods and are subject to change without notice. This material is presented for informational purposes only and is not an offer, recommendation or solicitation regarding any financial product or service or as a determination that any investment strategy is suitable for a specific investor. Investors should seek financial advice regarding the suitability of any investment strategy based on the investor’s objectives, financial situation and particular needs. The investments or investment strategies discussed may not be suitable for every investor. There is no assurance that any investment strategy will be successful. Some investment products may be available only to certain “qualified investors” — that is, investors who meet certain income and/or investable assets thresholds.
Performance is presented both gross and net of composite fees. The highest fee applicable for a separate account managed directly by Alpine Saxon Woods is 1.0% annually. (Strategies accessed through third-party wrap programs will pay fees as high as 3%.) Gross-of-fee returns reflect the impact of transaction costs but not the deduction of advisory fees. Net-of-fee (Net) returns reflect the deduction of all transaction costs and advisory fees to accounts in the composite. Actual fees and account minimums may vary. Indices, including index ETFs, are provided solely for illustrative purposes. Indices are not available for direct investment, and do not reflect the deduction of fees and trading costs, which would reduce returns. ETFs are similarly provided to illustrate particular industries or industry groups and are not recommendations for investment. ETF fees and expenses are lower (typically 0.10%-0.35%) than is typical for a managed account, which can exceed 1%.
The positions provided represent holdings as of the date shown and are subject to change without notice. Reported positions do not include all securities that were purchased, sold or held in client accounts over time. It should not be assumed that the holdings described are or will be profitable or that securities purchased in the future will be profitable or will equal the performance of the securities in this list. References to specific securities do not represent a recommendation to purchase or sell any particular security outside a managed account.
As of
September 30, 2026
Microsoft (MSFT) was the portfolio’s leading contributor for the quarter, rising as the skepticism over its AI spending that pressured the shares in the first half gave way to clear evidence of monetization. Azure revenue grew 43% in the June quarter, surpassing $100 billion in annual revenue, management guided to roughly 45% Azure growth in the current quarter, and Microsoft 365 Copilot passed 30 million paid seats; the volatility we used to add to our core position last quarter was well rewarded. CrowdStrike (CRWD) extended its advance after a strong late-August report, as its Falcon Flex licensing model gained traction and new distribution through the Anthropic and OpenAI enterprise marketplaces broadened its reach. Meta Platforms (META) recovered from an initial post-earnings selloff over higher capital spending guidance, as 28% revenue growth demonstrated that its AI investments are translating directly into advertising performance; we used that selloff to substantially increase the position, which is now our third-largest holding. SK Hynix (SKHY), the dominant supplier of high-bandwidth memory (HBM) for AI accelerators, was a strong contributor in its first quarter in the portfolio after we established a position through its record U.S. ADR listing in July. Finally, Thermo Fisher Scientific (TMO) rallied after a beat-and-raise second quarter in which revenue grew 10% and adjusted EPS rose 13%, as pharma and biotech demand — particularly bioproduction and clinical research — moved from stabilizing to accelerating.
Taken together, these results reflect the balance we have tried to strike: as the momentum-driven, hardware heavy segment of the AI trade corrected, our holdings in the platforms, software, and health care franchises with the most durable competitive advantages carried the portfolio. Snowflake (SNOW), which reported its third consecutive quarter of accelerating product revenue growth, narrowly missed our top five and is another example of AI demand flowing through to software.
As of
September 30, 2026
Marvell Technology (MRVL) was the largest detractor for the quarter, giving back a portion of its second-quarter advance amid the July semiconductor unwind. The company’s late-August results beat expectations, with record data center revenue up 46% and a raised fiscal 2027 outlook, but shares fell on lower gross margin guidance tied to a growing mix of custom AI silicon; we trimmed the position meaningfully during the quarter, though we continue to view Marvell as a core AI-infrastructure holding. Cummins (CMI) declined after second quarter earnings missed expectations on margin pressure, overshadowing higher full-year revenue guidance driven by data center power generation demand, as investors questioned how quickly that growth will convert into earnings; we exited the position and now express our view on data center power demand through Bloom Energy (BE). KLA Corp. (KLAC), a position we initiated and exited within the quarter, fell after in-line guidance, tariff and memory-pricing margin headwinds, and reports of Chinese state-backed progress in chipmaking equipment overshadowed a beat and a higher outlook for wafer fab equipment spending, compounding the broader semiconductor selloff. Monster Beverage (MNST) was pressured despite a strong second quarter with 20% revenue growth, as rising Treasury yields weighed on richly valued consumer names. With international revenue growing nearly 35%, we believe the growth story is intact and used the weakness to add to the position. Intel (INTC), a new position last quarter, declined from its late-June record high alongside the broader semiconductor group, in a sector-wide selloff and profit taking that, in our view, did not reflect a change in the company’s fundamentals; supply constraints remain the key limit on near-term revenue, and we added modestly on the decline.